Chinese Traditional and Herbal Drugs
|
2025, 56(3): 895-904
Effect of Cangai volatile oil on endoplasmic reticulum stress and airway remodeling in asthmatic mice by regulating TRPC1 signaling pathway
Full
WANG Tianzi, ZHENG Jialin, HUANG Huihui, LU Yingzhu, LI Zhuoqun, SI Manzhen, HE Xiying, WANG Ziwei, BIAN Ji, MING Xi
Affiliations
doi: 10.7501/j.issn.0253-2670.2025.03.016
Outline
Objective To investigate the effect of Cangai volatile oil (CAVO) on airway remodelling mediated by endoplasmic reticulum stress in asthmatic mice by intervening in the classical transient receptor potential canonical channel 1 (TRPC1) signalling pathway.Methods A total of 36 Balb/c mice were randomly divided into control group, model group, dexamethasone (1.50 mg/kg) group, and CAVO high-, medium- and low-dose (3.86, 1.93, 0.97 mg/kg) groups. In addition to control group, the rest of the groups of mice were sensitised by ovomucoid protein (OVA) to establish an asthma model. Each group ig corresponding drug (20 mL/kg) respectively, and control group and model group ig an equal amount of saline, once a day, for six weeks. After six weeks of administration, lung tissues were dissected for Western blotting to observe protein activating transcription factor 6 (ATF6), protein kinase RNA-like endoplasmic reticulum kinase (PERK), C/EBP homologous protein (CHOP), Collagen type I (Collagen I), Collagen III expression levels. A total of 20 SD rats were selected to prepare drug-containing serum, and the dosage of drug administered to SD rats was calculated according to the body surface area, and the drug was administered by gavage for 7 d, twice a day, and the rats were executed 1 h after the last administration, and the blood was taken and processed for spare parts. The alveolar lavage fluid of asthmatic mice was collected and purified to isolate alveolar macrophages, which were co-cultured with human bronchial epithelial cells 16HBE, and randomly divided into control group, 5% CAVO-containing serum group, 5% CAVO-containing serum + null-loaded group, and 5% CAVO-containing serum + TRPC1-overexpression group. Cells were collected and protein expression of ATF6, PERK, CHOP, Collagen Ⅰ, Collagen Ⅲ and TRPC1 were detected by Western blotting, the expression of Collagen Ⅰ, Collagen Ⅲ and TRPC1 in each group were detected by quantitative reverse transcription polymerase chain reaction (qRT-PCR). Results In vivo experiments revealed that the expression of ATF6, PERK, CHOP, Collagen I and Collagen III in the model group was significantly increased compared with the control group (P < 0.01), compared with the model group, the protein expression levels of ATF6, PERK, CHOP, Collagen I, and Collagen III in the CAVO high-, medium-, and low-dose group were significantly decreased (P < 0.05). In vitro experiments revealed that the expression levels of ATF6, PERK, CHOP, Collagen I, Collagen III, and TRPC1 were significantly decreased in the 5% CAVO-containing serum group and the 5% CAVO-containing serum + null group compared with the control group (P < 0.01), and in the 5% CAVO-containing serum + TRPC1-overexpression group, the expression levels of expression levels of ATF6, PERK, CHOP, Collagen I, Collagen III, and TRPC1 were significantly increased compared with 5% CAVO-containing serum + null-loaded group (P < 0.05).Conclusion CAVO treatment of asthma may be related to regulating the TRPC1 signaling pathway, affecting the endoplasmic reticulum stress response, and improving asthma airway remodeling.
Cangai volatile oil
/
bronchial asthma
/
endoplasmic reticulum stress response
/
TRPC1 signaling pathway
/
airway remodeling
/
eugenol
/
1,8-cineole
/
β-caryophyllene
/
eugenol acetate
王天资, 郑佳琳, 黄会惠, 卢盈竹, 李卓群, 司曼真, 贺喜盈, 王紫薇, 边际, 明溪.
苍艾挥发油调节TRPC1信号通路对哮喘小鼠内质网应激与气道重塑的影响.
中草药,
2025
, 56
(3)
: 895
-904
.
DOI: 10.7501/j.issn.0253-2670.2025.03.016
WANG Tianzi, ZHENG Jialin, HUANG Huihui, LU Yingzhu, LI Zhuoqun, SI Manzhen, HE Xiying, WANG Ziwei, BIAN Ji, MING Xi.
Effect of Cangai volatile oil on endoplasmic reticulum stress and airway remodeling in asthmatic mice by regulating TRPC1 signaling pathway[J].
Chinese Traditional and Herbal Drugs,
2025
, 56
(3)
: 895
-904
.
DOI: 10.7501/j.issn.0253-2670.2025.03.016
Year 2025 volume 56 Issue 3
50
8
Cite this Article
BibTeX
Article Info
doi: 10.7501/j.issn.0253-2670.2025.03.016
- Receive Date:2024-09-30
- Online Date:2026-11-13